MX376535B - Reacción enzimática en un solo recipiente para conjugación de polipéptido doble en un solo paso usando sortasa. - Google Patents

Reacción enzimática en un solo recipiente para conjugación de polipéptido doble en un solo paso usando sortasa.

Info

Publication number
MX376535B
MX376535B MX2017007204A MX2017007204A MX376535B MX 376535 B MX376535 B MX 376535B MX 2017007204 A MX2017007204 A MX 2017007204A MX 2017007204 A MX2017007204 A MX 2017007204A MX 376535 B MX376535 B MX 376535B
Authority
MX
Mexico
Prior art keywords
seq
polypeptide
sortase
amino acid
sub
Prior art date
Application number
MX2017007204A
Other languages
English (en)
Other versions
MX2017007204A (es
Inventor
Dieter Heindl
Erhard Kopetzki
Georg Tiefenthaler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2017007204A publication Critical patent/MX2017007204A/es
Publication of MX376535B publication Critical patent/MX376535B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/2207—Sortase A (3.4.22.70)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un método para producir un producto de la conjugación enzimática de tres polipéptidos, que comprende la incubación simultánea de i) un primer polipéptido que comprende la secuencia de aminoácido LPXTG (SEC ID NO: 20, en donde X puede ser cualquier residuo de aminoácido), un segundo polipéptido que comprende la secuencia de aminoácido LPXTA (SEC ID NO: 31, en donde X puede ser cualquier residuo de aminoácido), un tercer polipéptido que tiene dos extremos N-terminal por lo cual el polipéptido tiene una oligo-glicina Gm (m = 2 (SEC ID NO: 22), o 3 (SEC ID NO: 23), 0 4 (SEC ID NO: 24), o 5 (SEC ID NO: 25)) secuencias de aminoácidos en su primer extremo N-terminal y una oligo15 alanina Am (m = 2 (SEC ID NO: 26) , o 3 (SEC ID NO: 27) , o 4 (SEC ID NO: 28), o 5 (SEC ID NO: 29)) secuencias de aminoácidos en su segundo extremo N-terminal, un cuarto polipéptido con actividad de sortasa por lo cual el polipéptido se deriva de sortasa A de Staphylococcus aureus, y un quinto polipéptido con actividad de sortasa por lo cual el polipéptido se deriva de sortasa A de Streptococcus pyogenes y la recuperación del conjugado de la mezcla de reacción.
MX2017007204A 2014-12-17 2015-12-15 Reacción enzimática en un solo recipiente para conjugación de polipéptido doble en un solo paso usando sortasa. MX376535B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14198534 2014-12-17
PCT/EP2015/079692 WO2016096787A1 (en) 2014-12-17 2015-12-15 Enzymatic one-pot reaction for double polypeptide conjugation in a single step using sortase

Publications (2)

Publication Number Publication Date
MX2017007204A MX2017007204A (es) 2017-08-28
MX376535B true MX376535B (es) 2025-03-07

Family

ID=52338849

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007204A MX376535B (es) 2014-12-17 2015-12-15 Reacción enzimática en un solo recipiente para conjugación de polipéptido doble en un solo paso usando sortasa.

Country Status (11)

Country Link
US (1) US11162127B2 (es)
EP (1) EP3233906B1 (es)
JP (1) JP6605606B2 (es)
KR (1) KR20170098821A (es)
CN (1) CN107001446A (es)
BR (1) BR112017010888A2 (es)
CA (1) CA2966289A1 (es)
MX (1) MX376535B (es)
RU (1) RU2711364C2 (es)
SG (1) SG11201704627XA (es)
WO (1) WO2016096787A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3001941A1 (en) * 2015-10-30 2017-05-04 Nbe-Therapeutics Ag Anti-ror1 antibodies
CN106191015B (zh) * 2016-08-25 2019-09-13 北京大学 金黄色葡萄球菌分选酶a高效突变体
DK3810633T3 (da) * 2018-06-25 2024-01-15 Spero Therapeutics Inc Forbindelser

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
PT2032606E (pt) 2006-05-30 2014-02-05 Genentech Inc Anticorpos e imunoconjugados e respetivas utilizações
CN101490087B (zh) * 2006-05-30 2013-11-06 健泰科生物技术公司 抗体和免疫偶联物及其用途
US8247198B2 (en) 2007-09-21 2012-08-21 Friedrich Srienc Enzymatic processing in deep eutectic solvents
US8940501B2 (en) * 2009-01-30 2015-01-27 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
EP2403530B1 (en) 2009-02-27 2016-05-11 Massachusetts Institute of Technology Engineered proteins with high affinity for dota chelates
WO2012145522A2 (en) 2011-04-19 2012-10-26 Georgia Tech Research Corporation Deep eutectic solvent systems and methods
EP2726494B1 (en) * 2011-06-28 2017-01-04 Whitehead Institute For Biomedical Research Using sortases to install click chemistry handles for protein ligation
US9588110B2 (en) 2011-07-28 2017-03-07 Cell Signaling Technology, Inc. Multi component antibody based detection technology
WO2013153203A1 (en) 2012-04-12 2013-10-17 Technische Universiteit Eindhoven Pretreatment of lignocellulosic biomass and recovery of substituents using natural deep eutectic solvents/compound mixtures with low transition temperatures
WO2013177231A1 (en) 2012-05-21 2013-11-28 Massachusetts Institute Of Technology Translocation of non-natural chemical entities through anthrax protective antigen pore
US20140030697A1 (en) 2012-06-14 2014-01-30 Massachusetts Institute Of Technology Sortase-mediated modification of viral surface proteins
US9267127B2 (en) 2012-06-21 2016-02-23 President And Fellows Of Harvard College Evolution of bond-forming enzymes
ES2597228T3 (es) * 2012-06-27 2017-01-17 F. Hoffmann-La Roche Ag Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas
KR20150030744A (ko) 2012-06-27 2015-03-20 에프. 호프만-라 로슈 아게 표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Fc-영역 접합체의 제조 방법 및 그의 용도
WO2014055936A1 (en) 2012-10-04 2014-04-10 Integenx Inc. Preservation of biological materials in non-aqueous fluid media
GB201303666D0 (en) 2013-03-01 2013-04-17 Goldsborough Andrew S Sample fixation and stabilisation
WO2014145441A1 (en) * 2013-03-15 2014-09-18 The Trustees Of The University Of Pennsylvania Sortase-mediated protein purification and ligation
EP2777714A1 (en) 2013-03-15 2014-09-17 NBE-Therapeutics LLC Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
GB2529356B (en) 2013-04-28 2020-12-23 Genequantum Healthcare Co Ltd Novel linkers, coupling intermediates, conjugates, preparation method and application thereof
EP3693398A1 (en) 2013-05-10 2020-08-12 Whitehead Institute for Biomedical Research In vitro production of red blood cells with sortaggable proteins
US10260038B2 (en) 2013-05-10 2019-04-16 Whitehead Institute For Biomedical Research Protein modification of living cells using sortase

Also Published As

Publication number Publication date
EP3233906B1 (en) 2019-05-01
US20170314055A1 (en) 2017-11-02
JP2018505661A (ja) 2018-03-01
MX2017007204A (es) 2017-08-28
EP3233906A1 (en) 2017-10-25
JP6605606B2 (ja) 2019-11-13
KR20170098821A (ko) 2017-08-30
SG11201704627XA (en) 2017-07-28
CN107001446A (zh) 2017-08-01
RU2017122041A (ru) 2019-01-21
US11162127B2 (en) 2021-11-02
CA2966289A1 (en) 2016-06-23
BR112017010888A2 (pt) 2018-02-27
RU2017122041A3 (es) 2019-07-17
RU2711364C2 (ru) 2020-01-16
WO2016096787A1 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
PH12017500785A1 (en) INTERFERON a2B VARIANTS
AU2015212749A8 (en) Protein
WO2015130846A3 (en) Compositions and methods for the site-specific modification of polypeptides
MY176331A (en) Carbohydrate degrading polypeptide and uses thereof
NZ701125A (en) Improved chymosine enzyme variants
MX2013004127A (es) Polipeptidos con actividad permeasa.
AU2018253611A1 (en) Engineered pesticidal proteins
EP4442268A3 (en) Ctla-4 variant immunomodulatory proteins and uses thereof
EP4374913A3 (en) Novel human serum albumin mutant
MX2020005724A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
MX381723B (es) Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa.
MY189932A (en) Recombinant microorganism for improved production of alanine
PH12017500047A1 (en) Dual cistronic bacterial expression system
MX2015001542A (es) Metodo.
ZA201808214B (en) Production of a horseradish peroxidase-igg fusion protein
EP4674957A3 (en) Lactase enzymes with improved activity at low temperatures
NZ600540A (en) Ethanol production in non-recombinant hosts
MY169049A (en) Microorganisms for producing putrescine and process for producing putrescine using them
EA201591609A1 (ru) Варианты альфа-амилазы
AU2015344324A8 (en) Endoxylanase mutant, enzyme composition for biomass decomposition, and method for producing sugar solution
MX2023014628A (es) Vectores de expresion, vectores libres de secuencias bacterianas y metodos para fabricar y usar los mismos.
MX2013014401A (es) Composiciones farmacéuticas basadas en shk y métodos para prepararlas y usarlas.
EP4043558A3 (en) Kaurenoic acid hydroxylases
MY187334A (en) Xylanase
BR112017010888A2 (pt) método para produzir um produto de conjugação enzimática de três polipeptídeos

Legal Events

Date Code Title Description
FG Grant or registration